ASIA-PACIFIC APHERESIS MARKET FORECAST 2021-2028

ASIA-PACIFIC APHERESIS MARKET FORECAST 2021-2028

  • May 2021 •
  • 168 pages •
  • Report ID: 6067973 •
  • Format: PDF
KEY FINDINGS
The Asia-Pacific apheresis market is anticipated to project a CAGR of 9.05% during the forecast period, 2021-2028. The increasing number of government initiatives, growing healthcare awareness, and blood donation camps are among the key growth enablers of the market.

MARKET INSIGHTS
Indonesia, Japan, China, Australia & New Zealand, India, South Korea, Thailand, Vietnam, and Rest of Asia-Pacific, are assessed for the growth analysis of the Asia-Pacific apheresis market.In Japan, the high awareness and initiatives to enhance the healthcare sector drive market growth.

The company increasingly prioritizes innovations in the medical field.Apheresis is used to treat several diseases in the country.

Low-density lipoprotein (LDL) apheresis has been developed to treat refractory familial hypercholesterolemia (FH).Further, almost 32% of Stage 3-5 chronic kidney disease patients are affected by anemia.

This is because anemia is propelled by declining kidney function. The senior population is on the rise, adding to the burden of increasing chronic diseases. These require blood processing. Such factors enable the market growth of Japan.
In South Korea, the rising chronic disease burden and the development of new products drive market growth.The Korean Journal of Internal Medicine in 2017 stated that plasma exchange was used in patients with severe fever with SFTS (thrombocytopenia syndrome).

The patients’ conditions improved as per the laboratory, clinical, and virological standards.Thus, plasma exchange is being evaluated as a therapeutic modality in rescue therapy for patients with rapidly progressing SFTS.

Moreover, the Ministry of Health and Welfare launched policies to enhance management and supervision functions in blood transfusion services to tackle challenges related to an imbalance in blood supply and demand. Such factors fuel market growth in South Korea.

COMPETITIVE INSIGHTS
Some of the key players in the market include Terumo Corporation (Terumo BCT), Miltenyi Biotec, Medicap Clinic GmbH, Kawasumi Laboratories Inc, Medica SPA, Kaneka Corporation, etc.

Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Companies mentioned
1. ASAHI KASEI CORPORATION
2. BAXTER INTERNATIONAL INC
3. B BRAUN MELSUNGEN AG
4. CERUS CORPORATION
5. CYTOSORBENTS CORPORATION
6. FRESENIUS SE & CO KGAA (FRESENIUS KABI AG)
7. HAEMONETICS CORPORATION
8. HEMACARE CORPORATION
9. INFOMED
10. KANEKA CORPORATION
11. KAWASUMI LABORATORIES INC
12. MEDICAP CLINIC GMBH
13. MEDICA SPA
14. MILTENYI BIOTEC
15. TERUMO CORPORATION (TERUMO BCT)